2025 National Medical Insurance Drug List Released with 114 New Additions, Including 50 Class 1 Innovative Drugs

Deep News

2025/12/07

The 2025 High-Quality Development Conference for Innovative Drugs was held this morning (December 7) in Guangzhou, where the 2025 National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List and the first edition of the Commercial Health Insurance Innovative Drug List were announced.

This marks the eighth adjustment to the National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List since the establishment of the National Healthcare Security Administration. The updated list includes 114 newly added drugs, 50 of which are Class 1 innovative drugs. The inaugural Commercial Health Insurance Innovative Drug List features 19 drugs, covering treatments ranging from CAR-T therapies for cancer to Alzheimer's disease medications that have garnered significant public attention.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1178186595"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1178186595\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1178186595?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-07 09:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178186595","market":"sg","top_or_hot":-1,"title":"2025 National Medical Insurance Drug List Released with 114 New Additions, Including 50 Class 1 Innovative Drugs","media":"Deep News","content":"<p>The 2025 High-Quality Development Conference for Innovative Drugs was held this morning (December 7) in Guangzhou, where the 2025 National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List and the first edition of the Commercial Health Insurance Innovative Drug List were announced.</p>\n<p>This marks the eighth adjustment to the National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List since the establishment of the National Healthcare Security Administration. The updated list includes 114 newly added drugs, 50 of which are Class 1 innovative drugs. The inaugural Commercial Health Insurance Innovative Drug List features 19 drugs, covering treatments ranging from CAR-T therapies for cancer to Alzheimer's disease medications that have garnered significant public attention.</p>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2025 National Medical Insurance Drug List Released with 114 New Additions, Including 50 Class 1 Innovative Drugs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2025 National Medical Insurance Drug List Released with 114 New Additions, Including 50 Class 1 Innovative Drugs\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time smaller\">2025-12-07 09:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>The 2025 High-Quality Development Conference for Innovative Drugs was held this morning (December 7) in Guangzhou, where the 2025 National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List and the first edition of the Commercial Health Insurance Innovative Drug List were announced.</p>\n<p>This marks the eighth adjustment to the National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List since the establishment of the National Healthcare Security Administration. The updated list includes 114 newly added drugs, 50 of which are Class 1 innovative drugs. The inaugural Commercial Health Insurance Innovative Drug List features 19 drugs, covering treatments ranging from CAR-T therapies for cancer to Alzheimer's disease medications that have garnered significant public attention.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159992","symbol_name":"創新藥","start_time":0,"source_url":"","article_id":"1178186595","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178186595","pubTimestamp":1765069818,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"The 2025 High-Quality Development Conference for Innovative Drugs was held this morning (December 7) in Guangzhou, where the 2025 National Basic Medical Insurance, Maternity Insurance, and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159992":"创新药","BK1574":"生物医药B类股","06978":"永泰生物-B","BK1161":"生物科技"},"translate_title":"2025年国家医保药品目录发布新增114个1类创新药50个","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"06978":1},"content_text":"The 2025 High-Quality Development Conference for Innovative Drugs was held this morning (December 7) in Guangzhou, where the 2025 National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List and the first edition of the Commercial Health Insurance Innovative Drug List were announced.\nThis marks the eighth adjustment to the National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List since the establishment of the National Healthcare Security Administration. The updated list includes 114 newly added drugs, 50 of which are Class 1 innovative drugs. The inaugural Commercial Health Insurance Innovative Drug List features 19 drugs, covering treatments ranging from CAR-T therapies for cancer to Alzheimer's disease medications that have garnered significant public attention.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}